Skip to main content

Health technology assessment

20
Jun 2017

Urolift for treatment of benign hyperplasia of prostate is on its way to establish add-on reimbursement in France

In May 2017, CNEDiMTS at the National Authority for Health (HAS) issued positive assessment of Urolift for add-on reimbursement via LPPR list. Added value was found to be minor in comparison with transurethral resection of prostate (TURP). This assessment provides better results compared to the earlier one in January 2017. Add-on reimbursement might be established within about one year period.
31
May 2017

French National Authority for Health (HAS) published new set of decisions by CNEDiMTS about add-on and medical aid reimbursement from the meetings in April and May

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 9 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May and April. Among others decision included MRI compatible and recharge free spinal cord stimulation devices, resorbable plates for osteosynthesis.